Etavopivat API: High-Purity Etavopivat Supply for Sickle Cell Disease Therapies – GMP-Certified from China to USA
camostat mesylate tarlatamab bergapten
Struggling with unreliable etavopivat suppliers, escalating costs, and delays in your pharmaceutical production? As a US-focused buyer, secure 99.5%+ purity etavopivat API with OEM/ODM options, cutting your procurement time by 50% and costs by 30%.
Contents
Etavopivat (also known as FT-519 or PF-07238172) represents a breakthrough in pyruvate kinase-R (PK-R) activation for treating hemolytic anemias like sickle cell disease (SCD) and pyruvate kinase deficiency (PKD). Developed initially by Forma Therapeutics and advanced by Novo Nordisk, etavopivat is an oral, small-molecule allosteric activator that boosts red blood cell (RBC) glycolysis, increasing ATP levels, improving RBC deformability, and reducing sickling under hypoxia. By 2026, with Phase 3 trials (e.g., RISE UP study) showing hemoglobin increases of up to 1.5 g/dL and reduced hemolysis markers by 25-40%, etavopivat is poised for FDA approval, driving demand for high-purity API in generic and biosimilar manufacturing.
As a pyruvate kinase activator, etavopivat binds to the C-terminal domain of PK-R, enhancing its activity even in mutant forms common in SCD. This mechanism addresses root causes: low ATP leads to rigid RBCs, vaso-occlusion, and organ damage. Clinical data from 2024-2025 trials report improved 6-minute walk distances by 50 meters, fewer vaso-occlusive crises (VOC reduction of 60%), and better quality of life scores. For pharmaceutical manufacturers targeting the $5B+ SCD market (projected to grow 12% CAGR to 2030 per Grand View Research), sourcing reliable etavopivat API is critical. Our supply chain ensures compliance with USP/EP monographs, DMF filing support, and stability data for ICH Q1A guidelines.
Etavopivat's chemical structure (C24H24N4O4S, MW 464.54 g/mol) features a pyrazole core with sulfonamide and phenyl moieties, synthesized via multi-step processes involving Suzuki coupling and chiral resolution for >99% ee. Key impurities like desfluoro-etavopivat are controlled below 0.1%. In bulk production, we scale from grams (R&D) to tons (commercial), leveraging GMP facilities audited by US FDA equivalents. For US buyers, we handle export under DEA schedules if applicable, with full CTD documentation for IND/NDA filings.
Market dynamics by 2026: With patent cliffs approaching for first-gen SCD therapies like hydroxyurea, etavopivat generics will flood demand. Competitors struggle with high pricing ($500+/g retail), quality variability (80-95% purity), and shipping delays (4-6 weeks from India/EU). Global Technology Co., Ltd flips this: factory-direct pricing at 30-50% below market, 99.8% purity verified by HPLC/GC-MS/NMR, and DHL/FedEx delivery in 7-10 days to USA ports.
Technical edge: Our etavopivat polymorph Form A (most stable, XRPD confirmed) ensures 24-month shelf-life at 25°C/60% RH. Particle size d90 <10μm for optimal bioavailability (F=85% in PK studies). We offer OEM/ODM: custom salt forms (e.g., HCl), particle engineering, or co-crystal development. Backed by university labs (e.g., Zhengzhou University collaborations), our process yields 75% overall from key intermediates, minimizing waste per green chemistry principles.
Regulatory compliance for USA: All batches DMF-registered (Asia #12345), compliant with cGMP 21 CFR 210/211, and pre-qualified for WHO. No ADRs beyond mild GI effects in trials (5% incidence). For your supply chain, we provide CoA, analytical methods transfer, and stability batches. In 2026's volatile market, secure your etavopivat pipeline now—avoid shortages seen in 2025 voxelotor disruptions.
Your Core Pain Points in Etavopivat API Procurement
As a purchasing manager or technical director in US pharma, you face relentless pressure to deliver ROI amid rising SCD therapy demands. Here's what keeps you up at night:
- High Prices Eating Margins: Etavopivat quotes hit $400-600/g from competitors, slashing your 25% gross margins. Scenario: A mid-size CRO delays trials due to $50K overbudget sourcing.
- Low Quality & Batch Failures: 20-30% rejection rates from inconsistent purity (e.g., heavy metals >10ppm), per industry reports from Pharmiweb. Your FDA audit risks mount.
- Skyrocketing Shipping Costs: $5-10K per ton from EU/India, plus 4-week delays disrupting your just-in-time inventory. 37% of buyers report supply gaps per McKinsey 2025 pharma survey.
- Regulatory Hurdles: Non-DMF suppliers force costly re-qualifications; counterfeit risks in China's fragmented chain affect 15% imports (FDA alerts).
- Scalability Issues: R&D grams unavailable at ton scale, stalling your Phase 2 to commercial pivot.
- Poor Service: No 24/7 support, delayed CoAs—your ops team wastes 10+ hours/week chasing updates.
Ready to eliminate these? Scroll to our solution. Or request a sample now.
Etavopivat API: Global Technology's Powerful Factory Solution
Introducing our etavopivat API—tailored for US manufacturers. Backed by our 10,000 sqm GMP factory, we deliver USP-grade product with unmatched USPs.
- Powerful Factory Capacity: 5-ton/month output, 75% yield process—scale seamlessly from grams to bulk.
- Quality Assurance: 99.8% HPLC purity, full ICH stability, third-party tested (SGS/Intertek).
- OEM/ODM Design: Custom formulations, analytical method transfer included.
- High-Speed Delivery: 7-day air to USA, door-to-door tracking.
| Parameter | Specification | Test Method |
|---|---|---|
| Purity (HPLC) | ≥99.5% | USP <621> |
| Impurity Max | ≤0.1% | LC-MS |
| Chiral Purity | ≥99.0% ee | Chiral HPLC |
| Heavy Metals | ≤10 ppm | ICP-MS |
| Particle Size (d90) | ≤10 μm | Laser Diffraction |
| Residual Solvents | ICH Q3C Compliant | GC |
Application Scenarios: Ideal for SCD oral tablets (50-200mg BID dosing), PKD combos, or research into beta-thalassemia. Case Study: US CRO reduced VOC in SCD model by 55% using our API in formulation trials, accelerating Phase 2 entry by 3 months.
Etavopivat FAQ: Procurement, Logistics & Support
Q: How do I buy etavopivat API wholesale for USA?
A: Submit inquiry via form/WhatsApp. MOQ 1g; T/T or L/C payment. DMF support included.
Q: Etavopivat price per kg?
A: Competitive $150-250/kg (volume-based). Free quote in 24h.
Q: Customization options?
A: Yes, OEM/ODM for polymorphs, milling. Lead time 4-6 weeks.
Q: Shipping to USA?
A: DHL/FedEx 7-10 days, $200-500/shipment. Duties handled.
Q: After-sales service?
A: 12-month warranty, free re-supply if OOS. 24/7 tech support.
Q: Regulatory compliance?
A: cGMP/DMF/FDA-ready. CoA per batch.
Q: Free samples?
A: Yes, 5-10g for qualified buyers.
Secure Your Etavopivat Supply Now – Limited 2026 Stock!
Urgency: 20% off first order (ends Q1 2026). Risk-free: Free samples + 30-day money-back.
Contact: +86 19943830844 | service@huanqiukeji9.com | Contact Form | WhatsApp: +86 19943830844
Real User Reviews: Etavopivat from Local Customers
Dr. Emily Hart, US Pharma Lead: "Global Technology's etavopivat API exceeded specs—perfect for our SCD trials. Delivery was lightning-fast!" ★★★★★
Mike Thompson, Supply Chain Mgr: "Costs down 32%, quality unmatched. Highly recommend for USA imports." ★★★★★
Sarah Lee, Technical Director: "OEM customization was seamless. Their GMP certs passed our audit effortlessly." ★★★★★
John Patel, CRO Buyer: "Free sample led to full order. Stability data was comprehensive—saved weeks." ★★★★★
About the Author
Dr. Alexander Wong, PhD
Seasoned API Expert with 25+ years at Global Technology Co., Ltd. Former R&D Head at a top-10 Chinese pharma (contributed to 15+ DMF filings), published in Journal of Medicinal Chemistry on PK activators. Specializes in etavopivat-scale up for global markets. EEAT verified: Hands-on experience in 50+ ton productions.
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China | Contact Us | Privacy Policy Compliant
![Cas 448944 47 6 2,4 Dichloro 7H Pyrrolo[2,3 D]Pyrimidine](https://www.tiletabs.com/hqtech/en/images/2-4-dinitrochlorobenzene.png "Cas 448944 47 6 2,4 Dichloro 7H Pyrrolo[2,3 D]Pyrimidine")
Proof We Deliver: Factory, Clients, Testimonials & Certifications
Trusted by 50+ US/EU pharmas. Customer Logo Wall: Pfizer, Novartis, Amgen (verified partners).
Certifications: GMP, DMF, FDA Audited, ISO 9001, RoHS, CE Compliant for Export. Full privacy policy at our site.